mesowatch
HomeWashington Appellate Upholds Mesothelioma Verdict
divider

Washington Appellate Upholds Mesothelioma Verdict Against Kaiser Gypsum

washington court

The Washington State Appeals Court has upheld a $13.5 million verdict against Kaiser Gypsum Co. Inc., (1) dismissing the company’s bid for a new trial in a lawsuit linking asbestos in its drywall joint compound to a man’s mesothelioma. The ruling, issued Tuesday, marks a significant victory for Raymond Budd and his wife, Vickie Budd, affirming the trial court’s decisions on various aspects of the case.

According to the lawsuit, Budd, who worked with Kaiser’s drywall joint compound from 1962 to 1972, was diagnosed with mesothelioma due to exposure to chrysotile asbestos in the product. The verdict in favor of the Budds was reached after a trial where Kaiser was the sole defendant.

Kaiser’s objections to several trial proceedings, including jury selection and the handling of trial transcripts, were dismissed by the appeals court. The court rebuffed Kaiser’s claims that COVID-19 precautions during jury selection compromised randomness, stating that the process was fair and within legal bounds.

Moreover, Kaiser’s efforts to correct a transcript error regarding expert testimony were rejected by the court, which deemed the error inconsequential to the jury’s verdict. The court emphasized that the jury was instructed to rely on testimony rather than transcripts as evidence.

In addressing Budd’s failure-to-warn claims, the court found sufficient evidence presented at trial, including testimony on proper warning standards and Budd’s adherence to product instructions, to support the jury’s findings.

The appeals court also upheld the trial court’s decisions regarding evidentiary matters, including the exclusion of certain prejudicial evidence and the admission of evidence regarding Kaiser’s products after Budd’s alleged exposure.

Responding to the ruling, Alexandra Brett Caggiano of Weinstein Caggiano PLLC, representing Budd, expressed satisfaction with the outcome, praising the trial court’s meticulous adherence to legal procedures. Caggiano credited the “very smart jury” for discerning the facts of the case.

Meanwhile, an attorney for Kaiser indicated that the company is reviewing the decision and may pursue further appeals.

The three-judge panel of the Court of Appeals of the State of Washington, comprising Judges John Chun, Lori Smith, and Stephen Dwyer, presided over the case.

Johnathan Edwards

Reading Time: 1 mins

Published On: February 23, 2022

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer